20
Participants
Start Date
November 6, 2024
Primary Completion Date
August 31, 2025
Study Completion Date
June 30, 2026
Roflumilast
Participants will ingest either a placebo or roflumilast 500mg in a single blind crossover study and receive transcranial magnetic stimulation to the primary motor cortex.
Placebo
Participants will ingest either a placebo or roflumilast 500mg in a single blind crossover study and receive transcranial magnetic stimulation to the primary motor cortex.
Intermittent theta-burst stimulation transcranial magnetic stimulation
Intermittent theta-burst stimulation consists of 2 second trains every 10 seconds. Each train is composed of 3 pulses at 50Hz, 200 milliseconds intervals given at 80% resting motor threshold. The total time for this treatment stimulus is 600 pulses over 190 seconds.
Continuous theta-burst stimulation transcranial magnetic stimulation
Continuous theta-burst stimulation consists of 2 second trains every 10 seconds. Each train is composed of 3 pulses at 50Hz, 200 milliseconds intervals given at 80% resting motor threshold. The total time for this treatment stimulus is 600 pulses over 40 seconds.
University of Calgary, Calgary
University of Calgary
OTHER